🔎 Trials Near Me

Home › Quitting Smoking › NCT07111936

Evaluating the Impact of CONNECT in a Multilingual Population

RecruitingHealthy volunteers welcome

Evaluating the Impact of CONNECT, a Novel Smoking Cessation Intervention, in a Diverse, Multilingual Population

Who can join

Ages 50 to 80 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Age 50-80 years old.
* Current smokers defined at smoking at least one cigarette in past 7 days AND eligible for lung cancer screening (LCS) based on smoking history (\>=20 pack year history)
* California (CA) residents
* Able to understand and comply with study procedures for the entire length of the study.
* Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria:

* Non-smokers.
* Individuals with a diagnosis of lung cancer.
* Individuals receiving hospice care.
* Individuals whose providers do not think that they should participate (e.g., psychiatric illness or significant cognitive impairment that would impede the individuals ability to participate).
* Hearing and/or vision disabilities that would prevent participants from adequately receiving treatment components such as video or telephone counseling.

About the study

This study aims to broaden the reach of the lung cancer screening (LCS) CONNECT program (NCT04149249, NCT06213532), by developing a version of the program to be available to multilingual communities. The CONNECT program encourages individuals who are undergoing lung cancer screening to also quit smoking by providing a personalized program which includes a video doctor with personalized responses, text message and telephone call support and connection with a pharmacist to assist in obtaining nicotine replacement medication. This clinical trial will develop and ultimately test how well the CONNECT Multilingual (CONNECT ML) program works to improve smoking cessation among current adult smokers within the Spanish and Cantonese speaking communities.

What is being tested

Sponsor: University of California, San Francisco · Participants: 439 · Started: Aug 7, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07111936

Locations in the U.S.

CaliforniaUniversity of California San Francisco, San Francisco

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.